Abiopharma

Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

ENLIVEX (ENLV) Files Form 6-K

Alterity Therapeutics Limited (ATHE) Files Form 6-K

Johnson & Johnson - Johnson & Johnson SubmitsOTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week

SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts